- Home
- JEQ vs COYA Comparison
JEQ vs COYA Comparison
Compare JEQ & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JEQ
- COYA
- Stock Information
- Founded
- JEQ 1990
- COYA 2020
- Country
- JEQ United States
- COYA United States
- Employees
- JEQ N/A
- COYA N/A
- Industry
- JEQ Air Freight/Delivery Services
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- JEQ Consumer Discretionary
- COYA Health Care
- Exchange
- JEQ Nasdaq
- COYA Nasdaq
- Market Cap
- JEQ 88.1M
- COYA 99.8M
- IPO Year
- JEQ N/A
- COYA 2022
- Fundamental
- Price
- JEQ $7.13
- COYA $5.51
- Analyst Decision
- JEQ
- COYA Strong Buy
- Analyst Count
- JEQ 0
- COYA 4
- Target Price
- JEQ N/A
- COYA $17.00
- AVG Volume (30 Days)
- JEQ 32.0K
- COYA 41.5K
- Earning Date
- JEQ 01-01-0001
- COYA 08-11-2025
- Dividend Yield
- JEQ 7.05%
- COYA N/A
- EPS Growth
- JEQ N/A
- COYA N/A
- EPS
- JEQ N/A
- COYA N/A
- Revenue
- JEQ N/A
- COYA $3,685,107.00
- Revenue This Year
- JEQ N/A
- COYA $105.26
- Revenue Next Year
- JEQ N/A
- COYA N/A
- P/E Ratio
- JEQ N/A
- COYA N/A
- Revenue Growth
- JEQ N/A
- COYA N/A
- 52 Week Low
- JEQ $4.99
- COYA $4.65
- 52 Week High
- JEQ $6.39
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- JEQ 52.12
- COYA 45.71
- Support Level
- JEQ $7.08
- COYA $5.30
- Resistance Level
- JEQ $7.87
- COYA $5.87
- Average True Range (ATR)
- JEQ 0.12
- COYA 0.38
- MACD
- JEQ -0.03
- COYA -0.01
- Stochastic Oscillator
- JEQ 5.70
- COYA 33.96
About JEQ abrdn Japan Equity Fund Inc.
Aberdeen Japan Equity Fund Inc is a United States-based closed-end diversified management investment company. Its investment objective is to outperform over the long term, on a total return basis (including appreciation and dividends), the Tokyo Stock Price Index ("TOPIX"). The fund seeks to achieve its investment objective by investing a majority of its assets, in equity securities of companies listed on the Tokyo Stock Exchange or listed on the over-the-counter market in Japan or listed on other stock exchanges in Japan. The portfolio of investments is spread across Consumer Discretionary, Industrials, Information Technology, Financials, and other sectors.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.